Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: Research Summary. . JAMA 2026 Aug 13:e2612679. doi: 10.1001/jama.2026.12679.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: Research Summary. JAMA 2026 Aug 13:e2612679. doi: 10.1001/jama.2026.12679.
PMID: 42593773